Missouri et al. v. Food and Drug Administration et al.

Why this Matters

The Plaintiffs allege that the Food and Drug Administration’s (FDA) approval and regulation of mifepristone as safe and effective violates the Administrative Procedure Act, the Food, Drug, and Cosmetic Act, the Comstock Act, and are ultra vires. Ensuring access to FDA-approved medication abortion enables patients to receive reproductive health care.

Potential Impact

Preventing women from accessing effective medication for abortion services will jeopardize their health and safety. Additionally, preventing the FDA from making clinical and scientific determinations will endanger the agency’s ability to ensure individuals have access to safe and effective drugs.